Texas invests $50M in psychedelic drug research to treat addiction
Medical Xpress
JUNE 16, 2025
But experts say the risks can be lowered through heart screenings, close monitoring and giving magnesium before and during treatment, The Times added in its report. The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. Food and Drug Administration (FDA).
Let's personalize your content